Association of polymorphisms in the LEDGF/p75 gene (PSIP1) with susceptibility to HIV-1 infection and disease progression

AIDS

Volumn 25, Issue 14, 2011, Pages 1711-1719

  Madlala, Paradise ^a   Gijsbers, Rik ^b   Christ, Frauke ^b   Hombrouck, Anneleen ^b   Werner, Lise ^c   Mlisana, Koleka ^c   An, Ping ^d   Abdool Karim, Salim S ^c   Winkler, Cheryl A ^d   Debyser, Zeger ^b   Ndung'U, Thumbi ^a,c  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b UNIVERSITY OF LEUVEN   (Belgium)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d SAIC FREDERICK INC   (United States)

Author keywords

Disease progression; HIV 1; HIV 1 integrase; Lens epitheliumderived growth factor p75 (LEDGF p75); PC4 or SFRS1 interacting protein 1 gene (PSIP1); single nucleotide polymorphisms; susceptibility to infection

Indexed keywords

LENS EPITHELIUM DERIVED GROWTH FACTOR; MESSENGER RNA; PROTEIN P75;

ARTICLE; CD4+ T LYMPHOCYTE; CHROMOSOME 9P; DISEASE COURSE; GENE; GENE MUTATION; GENETIC VARIABILITY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; NEGRO; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSIP1 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; SOUTH AFRICA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; DISEASE PROGRESSION; GENETIC PREDISPOSITION TO DISEASE; HIV INFECTIONS; HIV-1; HUMANS; INTEGRASES; MUTATION; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRANSCRIPTION FACTORS;

EID: 80052401667     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328349c693     Document Type: Article

References (36)

1. Greene WC, Debyser Z, Ikeda Y, Freed EO, Stephens E, Yonemoto W, et al. Novel targets for HIV therapy. Antiviral Res 2008; 80:251-265.
2. Dietz F, Franken S, Yoshida K, Nakamura H, Kappler J, Gieselmann V. The family of hepatoma-derived growth factor proteins: characterization of a new member HRP-4 and classification of its subfamilies. Biochem J 2002; 366:491-500. (Pubitemid 35001693)
3. Ganapathy V, Daniels T, Casiano CA. LEDGF/p75: a novel nuclear autoantigen at the crossroads of cell survival and apoptosis. Autoimmun Rev 2003; 2:290-297. (Pubitemid 37083497)
4. Ge H, Si Y, Wolffe AP. A novel transcriptional coactivator, p52, functionally interacts with the essential splicing factor ASF/SF. Mol Cell 1998; 2:751-759. (Pubitemid 128378983)
5. Sharma P, Singh DP, Fatma N, Chylack LT Jr, Shinohara T. Activation of LEDGF gene by thermal-and oxidative-stresses. Biochem Biophys Res Commun 2000; 276:1320-1324.
6. Shinohara T, Singh DP, Fatma N. LEDGF, a survival factor, activates stress-related genes. Prog Retin Eye Res 2002; 21:341-358. (Pubitemid 34607433)
7. Singh DP, Fatma N, Kimura A, Chylack LT Jr, Shinohara T. LEDGF binds to heat shock and stress-related element to activate the expression of stress-related genes. Biochem Biophys Res Commun 2001; 283:943-955. (Pubitemid 32924672)
8. Llano M, Vanegas M, Fregoso O, Saenz D, Chung S, Peretz M, et al. LEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexes. J Virol 2004; 78:9524-9537. (Pubitemid 39096559)
9. Maertens G, Cherepanov P, Pluymers W, Busschots K, De Clercq E, Debyser Z, et al. LEDGF/p75 is essential for nuclear and chromosomal targeting of HIV-1 integrase in human cells. J Biol Chem 2003; 278:33528-33539. (Pubitemid 37055807)
10. De Rijck J, Vandekerckhove L, Gijsbers R, Hombrouck A, Hendrix J, Vercammen J, et al. Overexpression of the lens epithelium-derived growth factor/p75 integrase binding domain inhibits human immunodeficiency virus replication. J Virol 2006; 80:11498-11509. (Pubitemid 44788865)
11. Hombrouck A, De Rijck J, Hendrix J, Vandekerckhove L, Voet A, De Maeyer M, et al. Virus evolution reveals an exclusive role for LEDGF/p75 in chromosomal tethering of HIV. PLoS Pathog 2007; 3:e47.
12. MacNeil A, Sankale JL, Meloni ST, Sarr AD, Mboup S, Kanki P. Genomic sites of human immunodeficiency virus type 2 (HIV-2) integration: similarities to HIV-1 in vitro and possible differences in vivo. J Virol 2006; 80:7316-7321. (Pubitemid 44092554)
13. Marshall HM, Ronen K, Berry C, Llano M, Sutherland H, Saenz D, et al. Role of PSIP1/LEDGF/p75 in lentiviral infectivity and integration targeting. PLoS One 2007; 2:e1340.
14. Cherepanov P. LEDGF/p75 interacts with divergent lentiviral integrases and modulates their enzymatic activity in vitro. Nucleic Acids Res 2007; 35:113-124. (Pubitemid 46189836)
15. Cherepanov P, Maertens G, Proost P, Devreese B, Van Beeumen J, Engelborghs Y, et al. HIV-1 integrase forms stable tetramers and associates with LEDGF/p75 protein in human cells. J Biol Chem 2003; 278:372-381. (Pubitemid 36043586)
16. Busschots K, Voet A, De Maeyer M, Rain JC, Emiliani S, Benarous R, et al. Identification of the LEDGF/p75 binding site in HIV-1 integrase. J Mol Biol 2007; 365:1480-1492. (Pubitemid 46070174)
17. Daelemans D, Lu R, De Clercq E, Engelman A. Characterization of a replication-competent, integrase-defective human immunodeficiency virus (HIV)/simian virus 40 chimera as a powerful tool for the discovery and validation of HIV integrase inhibitors. J Virol 2007.
18. Emiliani S, Mousnier A, Busschots K, Maroun M, Van Maele B, Tempe D, et al. Integrase mutants defective for interaction with LEDGF/p75 are impaired in chromosome tethering and HIV-1 replication. J Biol Chem 2005; 280:25517-25523. (Pubitemid 40962257)
19. Vandekerckhove L, Christ F, Van Maele B, De Rijck J, Gijsbers R, Van den Haute C, et al. Transient and stable knockdown of the integrase cofactor LEDGF/p75 reveals its role in the replication cycle of human immunodeficiency virus. J Virol 2006; 80:1886-1896. (Pubitemid 43228728)
20. An P, Wang LH, Hutcheson-Dilks H, Nelson G, Donfield S, Goedert JJ, et al. Regulatory polymorphisms in the cyclophilin A gene, PPIA, accelerate progression to AIDS. PLoS Pathog 2007; 3:e88.
21. Agrawal L, Lu X, Qingwen J, VanHorn-Ali Z, Nicolescu IV, McDermott DH, et al. Role for CCR5Delta32 protein in resistance to R5, R5X4, and X4 human immunodeficiency virus type 1 in primary CD4R cells. J Virol 2004; 78:2277-2287. (Pubitemid 38228921)
22. An P, Bleiber G, Duggal P, Nelson G, May M, Mangeat B, et al. APOBEC3G genetic variants and their influence on the progression to AIDS. J Virol 2004; 78:11070-11076. (Pubitemid 39299647)
23. An P, Duggal P, Wang LH, O'Brien SJ, Donfield S, Goedert JJ, et al. Polymorphisms of CUL5 are associated with CD4R T cell loss in HIV-1 infected individuals. PLoS Genet 2007; 3:e19.
24. Winkler C, An P, O'Brien SJ. Patterns of ethnic diversity among the genes that influence AIDS. Hum Mol Genet 2004; 13 (Spec No 1):R9-19. (Pubitemid 38443795)
25. Reddy K, Winkler CA, Werner L, Mlisana K, Karim SS, Ndung'u T. APOBEC3G expression is dysregulated in primary HIV-1 infection and polymorphic variants influence CD4R T-cell counts and plasma viral load. AIDS 2010; 24:195-204.
26. van Loggerenberg F, Mlisana K, Williamson C, Auld SC, Morris L, Gray CM, et al. Establishing a cohort at high risk of HIV infection in South Africa: challenges and experiences of the CAPRISA 002 acute infection study. PLoS One 2008; 3:e1954.
27. Brumme Z, Wang B, Nair K, Brumme C, de Pierres C, Reddy S, et al. Impact of select immunologic and virologic biomarkers on CD4 cell count decrease in patients with chronic HIV-1 subtype C infection: results from Sinikithemba Cohort, Durban, South Africa. Clin Infect Dis 2009; 49:956-964.
28. Kiepiela P, Ngumbela K, Thobakgale C, Ramduth D, Honeyborne I, Moodley E, et al. CD8R T-cell responses to different HIV proteins have discordant associations with viral load. Nat Med 2007; 13:46-53. (Pubitemid 46067385)
29. Bartholomeeusen K, Christ F, Hendrix J, Rain JC, Emiliani S, Benarous R, et al. Lens epithelium-derived growth factor/p75 interacts with the transposase-derived DDE domain of PogZ. J Biol Chem 2009; 284:11467-11477.
30. Bartholomeeusen K, De Rijck J, Busschots K, Desender L, Gijsbers R, Emiliani S, et al. Differential interaction of HIV-1 integrase and JPO2 with the C terminus of LEDGF/pJ. Mol Biol 2007; 372:407-421. (Pubitemid 47267963)
31. Gijsbers R, Ronen K, Vets S, Malani N, De Rijck J, McNeely M, et al. LEDGF hybrids efficiently retarget lentiviral integration into heterochromatin. Mol Ther 18:552-560.
32. Pauwels R, Andries K, Debyser Z, Kukla MJ, Schols D, Breslin HJ, et al. New tetrahydroimidazo [4,5,1-jk.][1,4]-benzodiazepin-2(1H)-one and-thione derivatives are potent inhibitors of human immunodeficiency virus type 1 replication and are synergistic with 2',3'-dideoxynucleoside analogs. Antimicrob Agents Chemother 1994; 38:2863-2870. (Pubitemid 24374449)
33. Zeger SL, Liang KY. Longitudinal data analysis for discrete and continuous outcomes. Biometrics 1986; 42:121-130.
34. Llano M, Saenz DT, Meehan A, Wongthida P, Peretz M, Walker WH, et al. An essential role for LEDGF/p75 in HIV integration. Science 2006; 314:461-464. (Pubitemid 44628966)
35. Busschots K, Vercammen J, Emiliani S, Benarous R, Engelborghs Y, Christ F, et al. The interaction of LEDGF/p75 with integrase is lentivirus-specific and promotes DNA binding. J Biol Chem 2005; 280:17841-17847. (Pubitemid 41389024)
36. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, et al. Identification of host proteins required for HIVinfection through a functional genomic screen. Science 2008; 319:921-926. (Pubitemid 351263756)